Tumor-associated osteoblastic bone metastases

Tumor-associated osteoblastic bone metastases are zones of abnormal new bone formation caused by the spread of certain cancers, most commonly prostate cancer and some subtypes of breast, lung, or other tumors, to the skeleton. Unlike osteolytic metastases, which are characterized by bone destruction, osteoblastic lesions involve stimulation of bone-forming osteoblasts by tumor-derived growth factors, leading to excessive and often disorganized deposition of new bone. These lesions can appear as sclerotic or heavily calcified areas on imaging studies. While they are less likely than osteolytic lesions to cause hypercalcemia, they can still result in pain, fracture, nerve compression, and significant morbidity. Importantly, "osteoblastic bone metastasis" does not refer to a single molecule, protein, or receptor, but to a pathological condition arising from complex tumor–bone interactions[2][5][1][4]. This entry is not appropriate as a molecular or pharmacological "target" for drug development or biomarker discovery in the usual sense. Instead, it denotes a manifestation of metastatic cancer affecting bone physiology, primarily resulting from aberrant osteoblast activation by tumor-secreted factors[2][5].

Other names

Osteoblastic bone metastasissclerotic bone metastasisblastic bone metastasis